|
Market Closed -
Euronext Paris
19:55:00 28/09/2026 +04
|
Pre-market 09:09:40 | |||
| 78.72 EUR | +1.76% |
|
78.94 | +0.28% |
Company Valuation: Eurofins Scientific SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 20,893 | 12,900 | 11,336 | 9,273 | 11,036 | 13,666 | - | - |
| Change | - | -38.26% | -12.13% | -18.2% | 19.02% | 23.83% | - | - |
| Enterprise Value (EV) 1 | 23,132 | 15,739 | 14,041 | 12,269 | 14,677 | 17,032 | 16,699 | 16,462 |
| Change | - | -31.96% | -10.79% | -12.62% | 19.63% | 16.04% | -1.95% | -1.42% |
| P/E | 27.8x | 22.2x | 45.4x | 26.9x | 28x | 26.2x | 20.7x | 17.5x |
| PBR | 4.49x | 2.7x | 2.24x | 1.73x | 2.56x | 2.91x | 2.65x | 2.45x |
| PEG | - | -1x | -0.8x | 0.7x | 1.3x | 0.8x | 0.8x | 0.9x |
| Capitalization / Revenue | 3.11x | 1.92x | 1.74x | 1.33x | 1.51x | 1.8x | 1.71x | 1.6x |
| EV / Revenue | 3.44x | 2.34x | 2.16x | 1.77x | 2.01x | 2.25x | 2.09x | 1.93x |
| EV / EBITDA | 12.2x | 10.4x | 10.3x | 7.91x | 8.94x | 9.73x | 8.81x | 7.98x |
| EV / EBIT | 15.7x | 15.2x | 16.7x | 12.1x | 13.6x | 15.1x | 13.4x | 11.9x |
| EV / FCF | 22.8x | 23.2x | 29.6x | 15.3x | 16.7x | 19.6x | 17.6x | 15.8x |
| FCF Yield | 4.39% | 4.3% | 3.38% | 6.53% | 5.97% | 5.11% | 5.69% | 6.32% |
| Dividend per Share 2 | 1 | 1 | 0.5 | 0.5 | 0.72 | 0.8025 | 0.9086 | 0.9603 |
| Rate of return | 0.92% | 1.49% | 0.85% | 1.01% | 1.15% | 1.02% | 1.15% | 1.22% |
| EPS 2 | 3.91 | 3.02 | 1.3 | 1.83 | 2.23 | 2.999 | 3.796 | 4.504 |
| Distribution rate | 25.6% | 33.1% | 38.5% | 27.3% | 32.3% | 26.8% | 23.9% | 21.3% |
| Net sales 1 | 6,718 | 6,712 | 6,515 | 6,951 | 7,296 | 7,583 | 7,998 | 8,529 |
| EBITDA 1 | 1,902 | 1,513 | 1,364 | 1,552 | 1,641 | 1,750 | 1,895 | 2,064 |
| EBIT 1 | 1,473 | 1,037 | 842 | 1,017 | 1,079 | 1,129 | 1,250 | 1,387 |
| Net income 1 | 783 | 606 | 310 | 406 | 475 | 530.9 | 659.7 | 817.4 |
| Net Debt 1 | 2,239 | 2,839 | 2,705 | 2,996 | 3,641 | 3,366 | 3,034 | 2,796 |
| Reference price 2 | 108.80 | 67.06 | 58.98 | 49.31 | 62.40 | 78.72 | 78.72 | 78.72 |
| Nbr of stocks (in thousands) | 192,035 | 192,365 | 192,194 | 188,049 | 176,864 | 173,599 | - | - |
| Announcement Date | 22/02/22 | 01/03/23 | 27/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.79x | 2.21x | 9.6x | 1.04% | 15.54B | |
| 33.26x | 5.97x | 17.88x | 0.98% | 49.06B | |
| 34.82x | 3.35x | 14.46x | -.--% | 44.6B | |
| -21.07x | 227.64x | -22.77x | -.--% | 43.24B | |
| 47.27x | 5.47x | 29.96x | -.--% | 41.73B | |
| 26.85x | 7.74x | 19.93x | 0.42% | 29.93B | |
| 35.19x | 5.78x | 26.24x | -.--% | 17.19B | |
| -61.04x | 9.99x | 243.78x | -.--% | 15.35B | |
| 77.82x | 4.11x | 15.72x | -.--% | 14.06B | |
| Average | 22.10x | 30.25x | 39.42x | 0.27% | 30.08B | |
| Weighted average by Cap. | 22.95x | 40.97x | 25.66x | 0.28% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ERF Stock
- Valuation Eurofins Scientific SE
Select your edition
All financial news and data tailored to specific country editions
